查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439252

化學品注入系統 - 全球市場考量、競爭格局、市場預測 (2030)

Drug Infusion System - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球藥物注射系統市場規模預計到2023年將達到117.3億美元，到2030年將達到194.5億美元，2024-2030年預測期間複合年增長率為8.85%。藥物注射系統的需求主要是由癌症和糖尿病等慢性病盛行率上升、老年人口不斷增加以及產品開發技術進步所推動的。

藥物注射系統的市場動態

由於各種癌症等慢性疾病的盛行率不斷上升，預計藥物注射系統市場將在預測期內顯著增長。例如，根據世界衛生組織（WHO）引用的數據（2022年），大約有226萬例乳腺癌、221萬例肺癌、193萬例結直腸癌和141萬例前列腺癌。到2020 年，全球將有109 萬例胃癌病例。

根據國際糖尿病聯盟（IDF）（2023）發布的統計數據，2021年全球有5.37億成年人患有糖尿病。預計到 2030 年，這一數字將增至 6.43 億，到 2045 年將增至 7.83 億。

上述事實是世界各地癌症和慢性病數量迅速增加的一個例子。慢性病通常會影響個體的一生，需要長期的治療介入。為此使用化學注射系統。藥物輸送系統是一種向患者輸送抗生素、止痛藥、荷爾蒙和化療等藥物和營養物質的醫療設備。這些系統有多種配置，包括固定式和移動式。這些設備可提供安全、準確的藥物輸送，無需持續確認劑量。

此外，技術的進步促進了可程式藥物輸注系統的發展，該系統提供流速和警報等功能，可輕鬆追蹤劑量。例如，B. Braun Melsugen AG 的 Space ecosystem是一個由 OnlineSuiteplus 支援的整合輸液系統。此整合系統提供連接和資料管理、標準化互通性、卓越護理和基於雲端的應用程式等功能。

然而，除了產品召回之外，與輸液系統相關的技術問題（例如斷開和校準問題）可能會對藥物輸液系統市場的成長產生一定的限制。

藥物注射系統市場細分分析

據估計，基於注射器的注射系統將在藥物注射系統市場的產品領域中佔據主要份額。

這是因為產品設計簡單，應用範圍廣泛。

注射幫浦廣泛應用於臨床環境。因此，將注射器連接到系統並根據您的要求對藥物輸送進行編程。

當需要少量藥物時，這些系統非常有用。

注射器注射系統特別適合對嬰兒、新生兒和幼兒等年輕患者進行給藥。

因此，注射器注射系統所提供的優勢將在預測期內增加其需求。

預計北美將主導整個藥物注射系統市場。

在所有地區中，預計北美將佔據藥物注射系統市場的最大份額。慢性背痛、糖尿病和癌症等慢性病的盛行率、完善的醫療保健系統、主要市場參與者的存在等預計將成為預測期內推動整體藥物注射系統市場增長的關鍵影響因素。 。

美國疾病管制與預防中心（CDC）提供的資訊顯示，根據National Health Survey 2019，到2019年，大約20.4%的成年人將患有慢性疼痛，7.4%的成年人會經常限制他們的工作或生活活動。患有慢性疼痛（被認為是高負擔慢性疼痛）。研究認為，高負擔慢性疼痛和慢性疼痛在 65 歲以上的人群中更為普遍，並且隨著年齡的增長而惡化。

該報告提供了全球藥物注射系統市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第1章 化學噴射系統市場報告簡介

第2章 藥物注射系統市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第3章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章 藥物注射系統市場關鍵因素分析

  • 藥物注射系統市場的驅動因素
    • 慢性病患病率增加
    • 癌症患病率增加
    • 老年人口增加
    • 產品開發創新
  • 藥物注射系統市場的抑制因素與挑戰
    • 頻繁的產品召回
    • 與設備相關的技術問題
  • 藥物注射系統市場機遇
    • 提高產品安全性
    • 改良的產品設計

第5章 藥物注射系統市場波特五力分析

第6章 藥物注射系統市場佈局

  • 按產品類型
    • 注射器注射系統
    • 彈性體注射系統
    • 大容量注射系統
    • 腸內輸液系統
    • PCA注射系統
    • 胰島素泵
    • 其他
  • 按置入性廣告
    • 體外的
    • 可植入的
  • 活動性別
    • 固定的
    • 移動的
  • 按用途
    • 腫瘤治療
    • 糖尿病
    • 鎮痛
    • 營養
  • 按最終用戶
    • 醫院
    • 門診手術中心
    • 居家護理環境
  • 按地區
    • 北美藥物注射系統市場規模（2021-2030）
    • 歐洲藥物注射系統市場規模（2021-2030）
    • 亞太地區藥物注射系統市場規模（2021-2030）
    • 其他地區化學注入系統市場規模（2021-2030年）

第7章 藥物注射系統市場公司及產品概況

  • B. Braun Melsungen AG
  • Medtronic
  • BD
  • PROMECON GmbH
  • arcomed ag
  • Fresnius Kabi AG
  • Microport Scientific Corporation
  • Teleflex Incorporated
  • Smiths Medical
  • Baxter
  • Ivenix Inc
  • Terumo Corporation
  • Insulet Corporation
  • FLOWONIX MEDICAL INC
  • Intera Oncology

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第11章 關於 DelveInsight

第12章 免責聲明與聯絡我們

Product Code: DIMDCL0039

Drug Infusion Systems Market By Product Type (Syringe Infusion Systems, Elastomeric Infusion Systems, Large Volume Infusion Systems, Enteral Infusion Systems, Patient-Controlled Analgesic Infusion Systems, Insulin Pumps, and Others), Product Placement (External and Implantable), Portability (Fixed and Ambulatory), Application (Oncotherapy, Diabetes, Analgesia, Nutrition, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of chronic diseases and increasing technological advancements

The global drug infusion systems market was valued at USD 11.73 billion in 2023, growing at a CAGR of 8.85% during the forecast period from 2024 to 2030 to reach USD 19.45 billion by 2030. The demand for drug infusion systems is primarily being boosted by the rising prevalence of chronic diseases such as cancer, diabetes, and others coupled with the increasing geriatric population and technological advancements in product development among others.

Drug Infusion Systems Market Dynamics:

The drug infusion systems market is slated to register significant growth in the forecast period due to the rising prevalence of various cancers and other chronic diseases. For instance, according to the data cited by the World Health Organization (WHO) 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.

As per the statistics published by the International Diabetes Federation (IDF) (2023), worldwide 537 million adults were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045.

The above-mentioned facts are examples of cancers and chronic diseases that are witnessing a rapid increase across the globe. Chronic diseases often impact individuals for the course of their lifetime and require therapeutic interventions for prolonged periods. To achieve that, drug infusion systems are used. Drug infusion systems are medical devices that are employed in the delivery of drugs such as antibiotics, pain relievers, hormones, and chemotherapy drugs as well as nutrients to the patients. These systems are available in various configurations such as stationary as well ambulatory ones. These devices offer a safe and accurate mode of drug delivery without the constant need for verifying the amount of dose being administered.

Moreover, technological advancements have led to the development of programmable drug infusion systems where flow rates and alarms among other features are being offered for easy tracking of the administered doses. For instance, the Space ecosystem by B. Braun Melsugen AG is an integrated infusion system that comes with the OnlineSuiteplus. This integrated system offers features such as connectivity and data management and standardized interoperability, outstanding therapy, and cloud-based applications among other features.

However, product recalls as well as technical problems associated with infusion systems such as disconnection, and issues in calibration may prove to be certain restraints to the drug infusion systems market growth.

Drug Infusion Systems Market Segment Analysis:

Drug Infusion Systems Market by Product Type (Syringe Infusion Systems, Elastomeric Infusion Systems, Large-Volume Infusion Systems, Enteral Infusion Systems, Patient-Controlled Analgesic Infusion Systems, Insulin Pumps, and Others), Product Placement (External and Implantable), Portability (Fixed and Ambulatory), Application (Oncotherapy, Diabetes, Analgesia, Nutrition, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment in the drug infusion systems market, syringe-based infusion systems are estimated to account for a significant share of the market.

This is due to their simple product design and wide applicability.

Syringe pumps are extensively used in clinical settings as the majority of the medications are available in syringe forms. Therefore, a syringe is fitted into the system and programmed for the delivery of the drug as per the requirement.

These systems are useful in the delivery of low medication volumes for medication required in small quantities.

Syringe infusion systems are particularly ideal for dose administration in younger patients such as babies, neonates, and young children.

Hence, owing to the advantages offered by syringe infusion systems, their demand will increase during the forecast period.

North America is expected to dominate the Overall Drug Infusion Systems Market:

Among all the regions, North America is expected to account for the largest share of the drug infusion systems market. The growing prevalence of chronic diseases such as chronic low back pain, diabetes, and cancers, a well-established healthcare system along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the drug infusion systems market over the forecast period.

As per the facts provided by the Centers for Disease Prevention and Control (CDC), according to the National Health Survey 2019, about 20.4% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited work or life activities (considered as high impact chronic pain) in 2019. It was observed in the survey that high-impact chronic pain and chronic pain affected people over 65 and above more commonly and worsen with age.

As per the figures mentioned by the American Cancer Society 2021, it was estimated that 1.9 million new cancer cases have been diagnosed in the United States in 2021. Also, according to the data provided by the CDC in 2021, around 1,752,735 new cases of cancer were reported in the US in 2019. As per Globocan 2021 data, there were around 61,152 new cases of leukemia recorded in 2020 in the United States.

As these indications require long-term disease management, drug infusion systems prove to be extremely useful devices in the administration of pain management therapies as well as chemotherapy.

Moreover, the US houses a large number of key players in the market which can be attributed to the conducive product development environment along with better opportunities in terms of market access to the end users.

In June 2019, Ivenix Inc received 510k approval from the US Food and Drug Administration for their Ivenix Infusion System, which was the first and only large-volume pump and infusion system designed with the new FDA infusion guidelines, first adopted in 2014.

Therefore, with the presence of a large patient pool, along with an active regulatory body as well as active key market players in the country and the region, the market outlook for drug infusion systems is expected to be promising in the US and North America.

Drug Infusion Systems Market Key Players:

Some of the key market players operating in the drug infusion systems market include B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, arcomed ag, Fresenius Kabi AG, Microport Scientific Corporation, Teleflex Incorporated., Smiths Medical, Baxter, Ivenix Inc, Terumo Corporation, Insulet Corporation., FLOWONIX MEDICAL INC, Intera Oncology and others.

Recent Developmental Activities in Drug Infusion Systems Market:

In September 2020, B. Braun Melsungen received 510k clearance from the US FDA for their SpaceStation MRI to allow Space® infusion pumps. These systems are meant for the delivery of medications to patients within the MRI suites.

In May 2020, Baxter received the CE mark approval and regulatory approval from Australia's Therapeutic Goods Administration (TGA) for their Evo IQ Syringe Infusion System. The system can be employed in the delivery of small volumes of fluids and other medications to patients in a controlled manner.

Key Takeaways from the Drug Infusion Systems Market Report Study

Market size analysis for current drug infusion systems market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global drug infusion systems market.

Various opportunities available for the other competitor in the drug infusion systems market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current drug infusion systems market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for drug infusion systems market growth in the coming future?

Target Audience who can be benefited from this Drug Infusion Systems Market Report Study

Drug infusion systems products providers

Research organizations and consulting companies

Drug infusion systems-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in drug infusion systems

Various End-Users who want to know more about the drug infusion systems market and the latest technological developments in the drug infusion systems market.

Frequently Asked Questions for Drug Infusion Systems Market:

1. What are drug infusion systems?

Drug Infusion Systems are medical devices that help in the administration of drugs such as pain relievers, antibiotics, and chemotherapy drugs to patients. These systems are also used in the administration of nutrients as well.

2. What is the market for global drug infusion systems?

The global drug infusion systems market was valued at USD 11.73 billion in 2023, growing at a CAGR of 8.85% during the forecast period from 2024 to 2030 to reach USD 19.45 billion by 2030.

3. What are the drivers for the global drug infusion systems market?

Some of the factors positively influencing the drug infusion systems market are the increasing prevalence of chronic diseases, and various cancers, the rising geriatric population, and technological advancement in product development.

4. Who are the key players operating in global drug infusion systems?

Some of the prominent market players operating in the drug infusion systems market include B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, arcomed ag, Fresenius Kabi AG, Microport Scientific Corporation, Teleflex Incorporated., Smiths Medical, Baxter, Ivenix Inc, Terumo Corporation, Insulet Corporation., FLOWONIX MEDICAL INC, Intera Oncology and others.

5. Which region has the highest share in the drug infusion systems market?

North America is expected to account for the highest revenue share in the drug infusion systems market during the forecast period. Factors such as access to better healthcare, a rising number of patients suffering from chronic diseases such as diabetes, and chronic back pain, and increasing product launches in the region are expected to drive the growth of the North American Drug Infusion Systems market.

Table of Contents

1. Drug Infusion Systems Market Report Introduction

2. Drug Infusion Systems Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Drug Infusion Systems Market Key Factors Analysis

  • 4.1. Drug Infusion Systems Market Drivers
    • 4.1.1. Increasing Prevalence of Chronic Diseases
    • 4.1.2. Rising Prevalence of Cancers
    • 4.1.3. Increasing Geriatric Population
    • 4.1.4. Technological Innovation in Product Development
  • 4.2. Drug Infusion Systems Market Restraints and Challenges
    • 4.2.1. Frequent Product Recalls
    • 4.2.2. Technical Challenges Associated with Devices
  • 4.3. Drug Infusion Systems Market Opportunities
    • 4.3.1. Improving Product Safety
    • 4.3.2. Improvement in Product Design

5. Drug Infusion Systems Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Drug Infusion Systems Market Layout

  • 6.1. By Product Type
    • 6.1.1. Syringe Infusion Systems
    • 6.1.2. Elastomeric Infusion Systems
    • 6.1.3. Large-Volume Infusion Systems
    • 6.1.4. Enteral Infusion Systems
    • 6.1.5. PCA Infusion Systems
    • 6.1.6. Insulin Pumps
    • 6.1.7. Others
  • 6.2. By Product Placement
    • 6.2.1. External
    • 6.2.2. Implantable
  • 6.3. By Portability
    • 6.3.1. Stationary
    • 6.3.2. Ambulatory
  • 6.4. By Application
    • 6.4.1. Oncotherapy
    • 6.4.2. Diabetes
    • 6.4.3. Analgesia
    • 6.4.4. Nutrition
    • 6.4.5. Others
  • 6.5. By End-User
    • 6.5.1. Hospitals
    • 6.5.2. Ambulatory Surgical Centers
    • 6.5.3. Homecare Settings
    • 6.5.4. Others
  • 6.6. By Geography
    • 6.6.1. North America Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.1.1. United States Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.1.2. Canada Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.1.3. Mexico Drug Infusion Systems Market Size in USD million (2021-2030)
    • 6.6.2. Europe Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.1. France Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.2. Germany Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.3. United Kingdom Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.4. Italy Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.5. Spain Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.2.6. Rest of Europe Drug Infusion Systems Market Size in USD million (2021-2030)
    • 6.6.3. Asia-Pacific Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.1. China Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.2. Japan Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.3. India Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.4. Australia Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.5. South Korea Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.3.6. Rest of Asia Pacific Drug Infusion Systems Market Size in USD million (2021-2030)
    • 6.6.4. Rest of the World (RoW) Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.4.1. Middle East Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.4.2. Africa Drug Infusion Systems Market Size in USD million (2021-2030)
      • 6.6.4.3. South America Drug Infusion Systems Market Size in USD million (2021-2030)

7. Drug Infusion Systems Market Company and Product Profiles

  • 7.1. B. Braun Melsungen AG
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Medtronic
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. BD
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. PROMECON GmbH
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. arcomed ag
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Fresnius Kabi AG
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Microport Scientific Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Teleflex Incorporated
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Smiths Medical
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Baxter
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Ivenix Inc
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Terumo Corporation
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Insulet Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. FLOWONIX MEDICAL INC
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Intera Oncology
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Drug Infusion Systems Market in Global (2021-2030)
  • Table 3: Drug Infusion Systems Market in Global by Product Type (2021-2030)
  • Table 4: Drug Infusion Systems Market in Global by Product Placement (2021-2030)
  • Table 5: Drug Infusion Systems Market in Global by Portability (2021-2030)
  • Table 6: Drug Infusion Systems Market in Global by Application (2021-2030)
  • Table 7: Drug Infusion Systems Market in Global by End-User (2021-2030)
  • Table 8: Drug Infusion Systems Market in Global by Geography (2021-2030)
  • Table 9: Drug Infusion Systems Market in North America (2021-2030)
  • Table 10: Drug Infusion Systems Market in the US (2021-2030)
  • Table 11: Drug Infusion Systems Market in Canada (2021-2030)
  • Table 12: Drug Infusion Systems Market in Mexico (2021-2030)
  • Table 13: Drug Infusion Systems Market in Europe (2021-2030)
  • Table 14: Drug Infusion Systems Market in France (2021-2030)
  • Table 15: Drug Infusion Systems Market in Germany (2021-2030)
  • Table 16: Drug Infusion Systems Market in the United Kingdom (2021-2030)
  • Table 17: Drug Infusion Systems Market in Italy (2021-2030)
  • Table 18: Drug Infusion Systems Market in Spain (2021-2030)
  • Table 19: Drug Infusion Systems Market in Rest of Europe (2021-2030)
  • Table 20: Drug Infusion Systems Market in Asia-Pacific (2021-2030)
  • Table 21: Drug Infusion Systems Market in China (2021-2030)
  • Table 22: Drug Infusion Systems Market in Japan (2021-2030)
  • Table 23: Drug Infusion Systems Market in India (2021-2030)
  • Table 24: Drug Infusion Systems Market in Australia (2021-2030)
  • Table 25: Drug Infusion Systems Market in South Korea (2021-2030)
  • Table 26: Drug Infusion Systems Market in Rest of Asia-Pacific (2021-2030)
  • Table 27: Drug Infusion Systems Market in Rest of World (2021-2030)
  • Table 28: Drug Infusion Systems Market in the Middle East (2021-2030)
  • Table 29: Drug Infusion Systems Market in Africa (2021-2030)
  • Table 30: Drug Infusion Systems Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Drug Infusion Systems Market in Global (2021-2030)
  • Figure 3: Drug Infusion Systems Market in Global by Product Type (2021-2030)
  • Figure 4: Drug Infusion Systems Market in Global by Product Placement (2021-2030)
  • Figure 5: Drug Infusion Systems Market in Global by Portability (2021-2030)
  • Figure 6: Drug Infusion Systems Market in Global by Application (2021-2030)
  • Figure 7: Drug Infusion Systems Market in Global by End-User (2021-2030)
  • Figure 8: Drug Infusion Systems Market in Global by Geography (2021-2030)
  • Figure 9: Drug Infusion Systems Market in North America (2021-2030)
  • Figure 10: Drug Infusion Systems Market in the US (2021-2030)
  • Figure 11: Drug Infusion Systems Market in Canada (2021-2030)
  • Figure 12: Drug Infusion Systems Market in Mexico (2021-2030)
  • Figure 13: Drug Infusion Systems Market in Europe (2021-2030)
  • Figure 14: Drug Infusion Systems Market in France (2021-2030)
  • Figure 15: Drug Infusion Systems Market in Germany (2021-2030)
  • Figure 16: Drug Infusion Systems Market in the United Kingdom (2021-2030)
  • Figure 17: Drug Infusion Systems Market in Italy (2021-2030)
  • Figure 18: Drug Infusion Systems Market in Spain (2021-2030)
  • Figure 19: Drug Infusion Systems Market in Rest of Europe (2021-2030)
  • Figure 20: Drug Infusion Systems Market in Asia-Pacific (2021-2030)
  • Figure 21: Drug Infusion Systems Market in China (2021-2030)
  • Figure 22: Drug Infusion Systems Market in Japan (2021-2030)
  • Figure 23: Drug Infusion Systems Market in India (2021-2030)
  • Figure 24: Drug Infusion Systems Market in Australia (2021-2030)
  • Figure 25: Drug Infusion Systems Market in South Korea (2021-2030)
  • Figure 26: Drug Infusion Systems Market in Rest of Asia-Pacific (2021-2030)
  • Figure 27: Drug Infusion Systems Market in the Rest of the World (2021-2030)
  • Figure 28: Drug Infusion Systems Market in the Middle East (2021-2030)
  • Figure 29: Drug Infusion Systems Market in Africa (2021-2030)
  • Figure 30: Drug Infusion Systems Market in South America (2021-2030)
  • Figure 31: Market Drivers
  • Figure 32: Market Barriers
  • Figure 33: Marker Opportunities
  • Figure 34: PORTER'S Five Force Analysis